Basic fibroblast growth factor: lysine 134 is essential for its neuroprotective activity.

Article Details

Citation

Copy to clipboard

Rose K, Kriha D, Pallast S, Junker V, Klumpp S, Krieglstein J

Basic fibroblast growth factor: lysine 134 is essential for its neuroprotective activity.

Neurochem Int. 2007 Jul;51(1):25-31. Epub 2007 Apr 19.

PubMed ID

17524524 [ View in PubMed

]

Abstract

Basic fibroblast growth factor (bFGF) is a heparin-binding growth factor known to cause cell proliferation, angiogenesis and neuroprotection. We have performed site-directed mutagenesis to identify the amino acids that are essential for heparin/growth factor interaction and for neuroprotection. Binding to heparin-acrylic beads was markedly reduced when lysine in position 134 of bFGF was replaced by alanine. Wildtype (wt)-bFGF was shown to protect rat primary cultures of embryonic hippocampal neurons against damage caused by staurosporine and to reduce the infarct size in mice after focal cerebral ischemia. These neuroprotective effects of wt-bFGF could not be shown for the mutant bFGF(K134A). Furthermore, phosphorylation of Akt and ERK1/2 was significantly reduced in cultured neurons treated with bFGF(K134A) indicating diminished intracellular signaling compared to neurons treated with wt-bFGF. In conclusion, lysine at position 134 of bFGF is essential for bFGF to bind heparin, then to interact with its receptor and, subsequently, to protect neurons against damage.

DrugBank Data that Cites this Article

Drug Targets

Drug	Target	Kind	Organism	Pharmacological Action	Actions
Heparin	Fibroblast growth factor 2	Protein	Humans	Unknown	Not Available	Details